For many SME's the re-opening of the economy, will be about looking for new ways to do business Evaluate risk at client application stage or run continuous credit checks on your full customer base.Satisfy due diligence requirments on Mallinckrodt Pharmaceuticals Ireland Limited in one single 'time-saving' search. Mallinckrodt Pharmaceuticals is an Irish–tax registered manufacturer of specialty pharmaceuticals (namely, adrenocorticotropic hormone), generic drugs and imaging agents. for patients and shareholdersWhere others see complexity, we see healthier livesWhere others see complexity, we see potential for growthFor more than 150 years, Mallinckrodt has been advancing the fields of science and medicine to improve the lives of people around the world.Grow your career, and become part of our legacy as we make a lasting difference in the lives of patients.Mallinckrodt is focused on developing innovative therapies and cutting-edge technologies for patients with severe and critical conditions and has products spanning all phases of clinical development.We are so grateful for all first responders, healthcare professionals and essential employees' efforts in the battle against COVID-19. Some aspects of the site may not function properly without cookies enabled.
The … Mallinckrodt Pharmaceuticals Ireland Limited was set up on Wednesday the 20th of August 2014. Identify key decision makers and pre-qualified new prospects for your sales and business development teams. Mallinckrodt Pharmaceuticals Ireland Limited was set up on Wednesday the 20th of August 2014. Mallinckrodt Pharmaceuticals Ireland Limited was registered on 20 Aug 2014 with its registered office in Ireland.
As they are non-CRO data, we can not vouch for their accuracy or timeliness. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland. Directors details are available to logged in users.
Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland. It is one of the many ways we demonstrate our commitment to being a leader in generic pharmaceuticals.Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company.© 2018 Mallinckrodt. Some aspects of the site may not function properly without cookies enabled. Dublin, Monday, 19 September 2016 – Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, today is officially opening its new offices in College Business and Technology Park in Blanchardstown, Dublin, and announcing creation of a new €10 million state-of-the-art Research and Development (R&D) facility at the location. The company's first directors were Aaron Keogh, Alasdair Fenlon, David Keenan. Their current partial address is Dublin 15, and the company status is Normal. Some aspects of the site may not function properly without cookies enabled. Mallinckrodt uses cookies to improve and analyze site functionality. To learn more about how we use cookies and how you can change your cookies settings, please read our A world leader in development and formulation expertise.Unparalleled quality, performance, supply continuity and customer service.Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company.© 2018 Mallinckrodt. We employ a vertically integrated process to ensure quality control during every step of the product’s development from active ingredient processing through formulation, manufacturing, and distribution. College Business & Technology Park, Cruiserath Road, Blanchardstown, Dublin 15, D15TX2V, Ireland The company has 6 directors who have also been the directors of 21 other Irish companies between them; 5 of which are now closed. In 2017 it generated 90% of sales from the U.S. healthcare system. Associated Debt Refinancing ActivitiesMallinckrodt supports a broad range of programs that encourage the appropriate prescribing, use, storage and disposal of pain medications.We pledge to create the best possible healthcare at the lowest possible cost for the greatest number of people.Building on our heritage and distinctive capabilities, our world-class development and formulation expertise bring medical solutions to the marketplace.Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company.© 2018 Mallinckrodt.